OptiScan Stock

optiscancorp.comHealthcare / Other HealthcareFounded: 1900Funding to Date: $207.05MM

Optiscan Biomedical is the developer of a monitoring platform for use in hospital intensive care units (ICUs) to support clinicians in detecting changes more rapidly in critically ill patients, enabling more timely intervention.

Register To Buy and Sell Shares

For more details on financing and valuation for OptiScan, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access OptiScan’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like OptiScan.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Carlo Mata
Director of Marketing
Patrick Nugent
Chief Financial Officer
Cary Vance
Chief Executive Officer, President & Board Member
Jim Causey
Vice President, Research & Development

Board Members

Paul Mieyal Ph.D
Wexford Capital
Phillip Stern
Chartline Capital Partners
Kenneth Abramowitz
NGN Capital
Aditya Puri
Xeraya Capital
Charles Liamos
MedVenture Associates

Frequently Asked Questions About OptiScan’s Stock

plusminus
Can you buy OptiScan’s stock?
OptiScan is not publicly traded on NYSE or NASDAQ in the U.S. To buy OptiScan’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell OptiScan’s stock?
Yes, you can sell stock of a private company like OptiScan. Forge can help you sell your OptiScan stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is OptiScan’s stock price?
OptiScan is a privately held company and therefore does not have a public stock price. However, you may access OptiScan’s private market stock price with Forge Data.
plusminus
What is OptiScan’s stock ticker symbol?
OptiScan does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

OptiScan Biomedical Announces Peer-Reviewed Publications Highlighting First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units | BioSpace
OptiScan Biomedical Announces Peer-Reviewed Publications Highlighting First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units - read this article along with other careers information, tips and advice on BioSpace
OptiScan Biomedical Completes $20M Series E Financing | FinSMEs
OptiScan Biomedical, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit, closed $20m Series E financing
OptiScan raises $20m for bedside glucose monitoring system
OptiScan Biomedical said today that it closed a $20 million Series E round to support the commercialization of its continuous monitoring system, the OptiScanner 5000, in the U.S. The company’s device is an automated bedside blood glucose monitor designed for use in the intensive care unit. The system can measure glucose values from a micro-sample of […]
Updated on: Apr 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.